A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

詳細情報 詳細情報について

• CRID

  1363388845054078720

• DOI

  10.1093/neuonc/nop015

• ISSN

  15235866

  15228517

• Web Site

  http://academic.oup.com/neuro-oncology/article-pdf/12/1/95/3852649/nop015.pdf

• データソース種別

  • Crossref